Last edition
News about "Fibroblast Activation Protein "
SOFIE Biosciences doses first patient in Phase III FAPI-PRO trial for pancreatic cancer imaging
SOFIE Biosciences has dosed the first patient in its Phase III FAPI-PRO trial evaluating 18F-FAPI-74 PET/CT for detecting metastatic pancreatic ductal adenocarcinoma, with 18 sites planned across 24 months.
Fibroblast Activation Protein | 13/02/2026 | By News Bureau
Telix Plans to Add FAP-Targeting Candidates to Theranostic Pipeline
Telix has entered into asset purchase and exclusive worldwide in-licence agreements for a suite of clinically validated FAP-targeting therapeutic and precision medicine (diagnostic) radiopharmaceutical candidates.
Fibroblast Activation Protein | 19/11/2024 | By Aishwarya | 583
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy